J Wang Chiang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
5504 Background: Extreme drug resistance (EDR) assays have been used as tools in identifying those agents that are least likely to be of clinical benefit in the treatment of epithelial ovarian cancer (EOC). We sought to examine the effect of obtaining EDR assays on the outcome of patients with EOC in the primary and recurrent setting. METHODS We conducted(More)
  • 1